The regulation of endocytic sorting and cholesterol transport by PTP1B-mediated ESCRT dephosphorylation at ER-endosome membrane contact sites
The regulation of endocytic sorting and cholesterol transport by PTP1B-mediated ESCRT dephosphorylation at ER-endosome membrane contact sites
批准号:
MR/P010091/1
负责人:
Clare Futter
金额:
$58.02万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The transport of proteins and lipids to the right cellular location is critical for the function of all cells. Endocytosis is a mechanism of uptake of extracellular molecules and cell surface membrane proteins into intracellular membrane compartments, called endosomes. Within the endosome, proteins and lipids are sorted. Unwanted cell membrane proteins and lipids can then be removed by delivering them to lysosomes where they are degraded. This degradative pathway is balanced by new synthesis of membrane proteins and lipids in the endoplasmic reticulum (ER). Overproduction or impaired degradation of membrane proteins or lipids can lead to multiple diseases, including cancer and lipid storage disorders. The degradative pathway is important for regulating signaling from growth factor receptors, such as the EGF receptor (EGFR), a cell surface signaling protein that regulates cell division. Dysregulated signaling from the EGFR occurs in about 50% of human cancers and is a target for cancer therapies. It activates signaling pathways by chemically modifying both itself and other signaling proteins. This modification, called phosphorylation, is reversible by dephosphorylation. The EGFR can be dephosphorylated by a phosphatase on the ER, PTP1B. Proteins and lipids can shuttle from cell membrane to membrane via small transport vesicles. Different cellular membranes can also form membrane contacts where they come very close together to form sites where proteins on the apposing membranes can interact and lipids can be flipped directly from one membrane to the other. We recently found that the ER and the endocytic pathway form membrane contacts and have identified molecules that tether the apposing membranes at the contact. We showed that ER:endosome membrane contacts are necessary for PTP1B to dephosphorylate endocytosed EGFR, and that PTP1B activity promotes delivery of EGFR to the lysosome for degradation. Some of the molecules that regulate lysosomal delivery of EGFR are themselves regulated by PTP1B-mediated dephosphorylation and one of those molecules, Hrs, has also been implicated in cholesterol exchange between endosomes and the ER.Cholesterol is a critical component of cell membranes obtained by endocytosis of dietary LDL, or by new synthesis in the ER. Excess endocytosed cholesterol is transferred to the ER and packaged into lipid droplets for storage. However, the endocytic pathway needs a certain amount of cholesterol to function. So when LDL-derived cholesterol is low, newly synthesized cholesterol is transferred from the ER to endosomes. We showed that ER:endosome membrane contacts regulate exchange of cholesterol between the ER and endosomes. Regulation of endosomal cholesterol is important for multiple processes. Endosomal cholesterol is required for normal function of the degradative pathway, but impaired egress of endosomal LDL-cholesterol is associated with lipid storage diseases, such as the childhood neurological disorder, Neimann Pick Type C disease. We hypothesise that PTP1B-mediated dephosphorylation of Hrs at membrane contact sites co-ordinates lysosomal targeting of EGFR and cholesterol exchange between endosomes and the ER. We will test this hypothesis using tools we've developed to manipulate membrane contacts, together with high-resolution electron microscopy (the only way to unequivocally identify membrane contacts) and newly developed super resolution microscopy techniques. Together these studies will provide a better understanding of how PTP1B activity at membrane contact sites regulates EGFR signaling and cholesterol exchange. This will determine how the relationship between PTP1B and EGFR can be exploited for the design of better combination cancer therapies and may yield novel therapeutic targets for the treatment of lipid storage diseases.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1093/hmg/ddx149
发表时间:
2017-07-15
期刊:
Human molecular genetics
影响因子:
3.5
作者:
[Agrawal SA, Burgoyne T, Eblimit A, Bellingham J, Parfitt DA, Lane A, Nichols R, Asomugha C, Hayes MJ, Munro PM, Xu M, Wang K, Futter CE, Li Y, Chen R, Cheetham ME]
通讯作者:
Cheetham ME
DOI:
10.4049/jimmunol.1600823
发表时间:
2017-05-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Dragoni S, Hudson N, Kenny BA, Burgoyne T, McKenzie JA, Gill Y, Blaber R, Futter CE, Adamson P, Greenwood J, Turowski P]
通讯作者:
Turowski P
DOI:
10.1177/2515256419893507
发表时间:
2019-01-01
期刊:
Contact (Thousand Oaks (Ventura County, Calif.))
影响因子:
--
作者:
[Enrich, Carlos, Rentero, Carles, Eden, Emily R]
通讯作者:
Eden, Emily R
DOI:
10.1371/journal.pone.0191048
发表时间:
2018
期刊:
PloS one
影响因子:
3.7
作者:
[Burgoyne T, Lane A, Laughlin WE, Cheetham ME, Futter CE]
通讯作者:
Futter CE
ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 Presentation.
DOI:
10.1016/j.celrep.2018.06.066
发表时间:
2018-07-17
期刊:
Cell reports
影响因子:
8.8
作者:
[Monypenny J, Milewicz H, Flores-Borja F, Weitsman G, Cheung A, Chowdhury R, Burgoyne T, Arulappu A, Lawler K, Barber PR, Vicencio JM, Keppler M, Wulaningsih W, Davidson SM, Fraternali F, Woodman N, Turmaine M, Gillett C, Franz D, Quezada SA, Futter CE, Von Kriegsheim A, Kolch W, Vojnovic B, Carlton JG, Ng T]
通讯作者:
Ng T
共 7 条
Molecular mechanisms regulating traffic of EGF receptor and their role in modulating responses to cancer therapeutics
-
批准号:G1001684/1
-
项目类别:Research Grant
-
资助金额:$57.29万
-
财政年份:2011
-
负责人:Clare Futter
-
依托单位:
Formation and function of membrane contact sites between the ER and the endocytic pathway
-
批准号:G0801878/1
-
项目类别:Research Grant
-
资助金额:$61.52万
-
财政年份:2009
-
负责人:Clare Futter
-
依托单位:
The role of multivesicular endosomes and OA1 in melanosome biogenesis
-
批准号:BB/D011841/1
-
项目类别:Research Grant
-
资助金额:$27.79万
-
财政年份:2006
-
负责人:Clare Futter
-
依托单位:
国内基金
海外基金
登录
查看更多内容
BNIP-2调控E-cadherin细胞内分选运输的机制研究
-
批准号:32100540
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2021
-
负责人:陈冰
-
依托单位:
CapZβ在早期内体成熟中的功能及分子机制研究
-
批准号:32070702
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:岳剑波
-
依托单位:
活细胞高分辨率成像解析clathrin介导的内吞囊泡形成早期内体的分子机制
-
批准号:31970659
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2019
-
负责人:何康敏
-
依托单位:
NSCLC细胞的EGFR、E-cad亚细胞定位与曲古抑菌素A逆转EGFR-TKI耐药的机制研究
-
批准号:81101771
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:项轶
-
依托单位:
EHD 蛋白对ErbB/Her 受体在细胞内转运调控的机制研究
-
批准号:30772528
-
项目类别:面上项目
-
资助金额:29.0万元
-
批准年份:2007
-
负责人:应国光
-
依托单位: